CSS Informatics Releases eLoader 3.5
PPD, Inc. announced that CSS Informatics, the clinical and safety data management consulting services and proprietary e-technologies division within PPD, has released an enhanced version of its specialized software product, eLoader. Used by pharmaceutical companies to convert study data from external systems to the Oracle® Clinical format, eLoader 3.5 now loads trial protocol information into Oracle Clinical in addition to loading patient response data.
This advance establishes eLoader as the only technology that provides a gateway for loading data directly from any external source into Oracle Clinical and Oracle Thesaurus Management System (TMS). The improved technology allows companies to move data from labs, electronic data capture systems, external vendors, data management systems and other sources into Oracle Clinical. In addition, eLoader 3.5 also expands the types of patient response data files that can be loaded into Oracle Clinical to include text, table, CDISC ODM and SAS Transport, making it the only direct interface between these structures and Oracle Clinical.
“The enhanced capabilities of eLoader represent a significant advance for clients in managing their clinical and safety data,” said Larry Kaufman, vice president of CSS Informatics. “A company running an independent patient recruitment tool can have that information loaded directly into Oracle Clinical without manual intervention, thus simplifying and speeding the processing and validation of data.”
With offices in the U.S. and Europe, CSS Informatics is a division within PPD. As a leading global provider of discovery and development services and products for pharmaceutical, biotechnology and medical device companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven early discovery through post-market resources, the company also offers compound partnering opportunities. PPD has more than 6,000 professionals in 27 countries around the world. For more information on PPD, visit our Web site at http://www.ppdi.com .
Except for historical information, all of the statements, expectations and assumptions, including expectations and assumptions about PPD’s enhanced version of eLoader, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making those forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: rapid technological advances that make our products and services less competitive; competition within the software industry; the ability to attract and retain key personnel; loss of large contracts; economic conditions and outsourcing trends in the pharmaceutical, biotechnology and medical device industries; risks associated with acquisitions and investments; continued success in sales growth; and other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.
Oracle is a registered trademark of Oracle Corp. and its affiliates.
